Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients
Recruiting · NCT07062263 · Registry updated 2025-07-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients | Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract cancer, biliary tract disorder, neoplasm | Recruiting | Phase 3 | 2025-07-14 | NCT07062263 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Tata Memorial Centre | 50 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Homi Bhabha Cancer Hospital and Research Centre | Mūllānpur | India | 1 |
| Homi Bhabha Cancer Hospital and Research Centre, Muzaffarpur | Muzaffarpur | India | 1 |
| Institute of Medical Sciences & SUM Hospital | Bhubaneswar | India | 2 |
| Mahamana Pandit Madan Mohan Malviya Cancer Centre (MPMMC) and Homi Bhabha Cancer Hospital (HBCH) | Varanasi | India | 1 |
| MAX Super Speciality Hospital, SAKET | Delhi | India | 1 |
| Tata Memorial Hospital | Mumbai | India | 42 |